EUVIMEDSkopri EUVIMED
EUVIMED · CrossrefJournal

Frontiers in Immunology

ISSN 1664-3224 · Frontiers Media SA

Latest articles

  1. A common HLA haplotype is associated with reduced fever during acute COVID-19 in two independent cohorts

    Liam Quinn, Frederikke Byron Pedersen, Lea Arregui Nordahl Christoffersen, Thorsten Brodersen, Andrew J. Schork, Khoa Manh Dinh, Morten Nielsen, Bjarke Feenstra, Frank Geller, Lasse Skafte Vestergaard, Susanne Gjørup Sækmose, Bitten Aagaard, Karina Banasik, Sofie Bliddal, Lasse Boding, Søren Brunak, Jonas Bybjerg-Grauholm, Maria Didriksen, Ulla Feldt-Rasmussen, Kirsten Grønbæk, Henrik Hjalgrim, Kathrine Agergård Kaspersen, Christina Mikkelsen, Claus Henrik Nielsen, Henriette Svarre Nielsen, Susanne Dam Nielsen, Janna Nissen, Niels Tommerup, Henrik Ullum, Peter Bager, Anders Hviid, Erik Sørensen, Sisse Rye Ostrowski, Christian Erikstrup, Ole Birger Vesterager

    Published: 2026-11-19DOI: 10.3389/fimmu.2026.1922935

  2. Epitope-guided Mycobacterium tuberculosis Zmp1 peptide-associated outer membrane vesicles enhance humoral responses to a heterologous antigen SARS-CoV-2 RBD-S2

    Omkar Shriram Zade, Rajanikant Panda, Sriram Yandrapally, Abhishek Guggilla, Akshay Vaijinath Gaikwad, Simran Srivastava, Warisha Faiz, Jaya Bharti, Prabal Basumatary, Krishnaveni Mohareer, Saima Naz, Keerthana Choudari, Pramod R. Somvanshi, Rajesh Ringe, Raghavan Varadarajan, Sharmistha Banerjee

    Published: 2026-11-19DOI: 10.3389/fimmu.2026.1947425

Volumes

2026 · 9,4972025 · 7,0312024 · 5,5242023 · 6,5002022 · 8,2212021 · 6,1282020 · 3,5422019 · 3,0902018 · 3,1702017 · 1,9202016 · 6792015 · 1,0352014 · 6832013 · 1,7222012 · 4172011 · 1032010 · 3

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.